Department of Nursing, Chang Gung University of Science and Technology, Taoyuan 333, Taiwan.
Division of Endocrinology and Metabolism, Department of Internal Medicine, Chang Gung Memorial Hospital, Taoyuan 333, Taiwan.
Int J Environ Res Public Health. 2021 Sep 10;18(18):9559. doi: 10.3390/ijerph18189559.
The purpose of this study was to evaluate the effects of a hypoglycemia problem-solving program (HPSP) on problem-solving ability and glycemic control in diabetics with hypoglycemia. This was a prospective, quasi-experimental study with two groups, using a pre- and post-repeated measures design. A total of 71 diabetic patients with hypoglycemia were purposively assigned to an experimental group ( = 34) and a control group ( = 37). The experimental group participated in an 8-week HPSP, and each weekly session lasted approximately 90 min, while the control group received usual care. Participants were assessed at baseline, 1, 3, and 6 months after intervention care. In the experimental group, 6 months after the HPSP intervention, HbA1c was superior to that before the intervention. In both groups, the score obtained using the hypoglycemia problem-solving scale (HPSS) was low before the intervention. In the experimental group, HPSS tracking improved at all stages after the intervention compared to before the intervention. In the control group, the HPSS score improved slightly in the first month and sixth months after usual care. There were significant differences between and within groups in HbA1c levels and HPSS score over time. The intervention based on the HPSP effectively improves HbA1c level and hypoglycemia problem-solving ability in patients with hypoglycemia.
本研究旨在评估低血糖问题解决计划（HPSP）对低血糖糖尿病患者解决问题能力和血糖控制的影响。这是一项前瞻性、准实验研究，采用前后重复测量设计，共纳入 71 例低血糖糖尿病患者，分为实验组（n=34）和对照组（n=37）。实验组参加了为期 8 周的 HPSP，每周一次，每次约 90 分钟，对照组接受常规护理。在干预前、干预后 1、3 和 6 个月进行评估。在实验组中，HPSP 干预 6 个月后 HbA1c 优于干预前。两组患者在干预前的低血糖问题解决量表（HPSS）评分均较低。在实验组中，与干预前相比，干预后各阶段的 HPSS 评分均有所提高。在对照组中，常规护理后第一个月和第六个月 HPSS 评分略有提高。HbA1c 水平和 HPSS 评分在组间和组内随时间均有显著差异。基于 HPSP 的干预可有效改善低血糖患者的 HbA1c 水平和低血糖问题解决能力。
